Pharmacology
News
FDA approves elranatamab for multiple myeloma
Elranatamab previously received Breakthrough Therapy Designation for relapsed or refractory multiple myeloma.
Conference Coverage
Noteworthy advances in treatment and management of IBD
A team of leading GI clinicians describes the most noteworthy achievements in IBD research over the last year.
News
Bulevirtide shows promise in chronic hepatitis D
There is no approved treatment for a hepatitis D virus infection which affects between 10 and 20 million people worldwide.
News
Experts highlight benefits and offer caveats for first postpartum depression pill
“A fast-acting pill that can be taken orally could be an ideal option for the 15% to 20% of women who experience postpartum depression.”
News
‘Triple G’ agonist hits new weight loss heights
This level of weight loss is “unprecedented” for a medication administered for 48 weeks.
Latest News
Medical treatment for appendicitis effective long-term
Some patients (29%) who initially received antibiotics required surgery up to 20 years later.
News
For CLL, BTKi combo bests chemoimmunotherapy
Phase 3 FLAIR trial yields more evidence that younger patients fared better with two-drug combo than with FCR, the once-standard therapy.
Latest News
Generic inhalers for COPD support hold their own
“I don’t see a clinical reason why one would ever need to get the brand name over the generic version.”
News
Ancestry may predict bipolar patients’ response to lithium
Responders to lithium for BPD were less likely than nonresponders to be of African ancestry, and more likely of European ancestry.
Latest News
Semaglutide cuts cardiovascular events in landmark trial